Literature DB >> 28612794

Injection practices in India.

Narendra K Arora1.   

Abstract

BACKGROUND: About 16 billion injections are administered each year worldwide, and at least half of them are unsafe. India contributes 25% to 30% of the global injection load. A majority of curative injections are unnecessary. The present study was undertaken to assess the burden of injections and prevalent injection practices in India.
METHODS: A nationwide population-based cluster survey (1200 clusters; 24 021 subjects) at household level; along with observations, interview of prescribers (2402), and exit interview of the patients (12 012) at health facility level in the selected clusters was carried out -using probability proportionate to size (PPS) technique. Observations at health facility included generic observation (3592), observation of injection process (17 844), and observation of prescriber-client interaction (24 030).
RESULTS: The frequency of injections was 2.9 (95%CI: 2.8-3.2) per person/year. Of the total injections, 62.9% (95%CI: 60.7-65.0) were unsafe. Injections administered for curative purpose constituted 82.5% and a large majorly of these were prescribed for common symptoms like fever/cough/diarrhoea. Use of glass syringes was consistently associated with potential risk of blood-borne viral transmission. Satisfactory disposal of injection waste was observed at 61.3% (95%CI: 58.2-64.3) of the health facilities, and at 50.9% (95%CI: 46.7-55.2) of the immunization clinics. Significant differences were observed in the injection prescription pattern in public and private facilities, and in rural and urban areas.
CONCLUSIONS: Three billion injections were estimated to be administered annually in India; of them 1.89 billion were unsafe. Evidence suggests that the micro-level leadership for reducing injection overuse and making injections safer lies with the prescriber.

Entities:  

Year:  2012        PMID: 28612794     DOI: 10.4103/2224-3151.206931

Source DB:  PubMed          Journal:  WHO South East Asia J Public Health        ISSN: 2224-3151


  11 in total

Review 1.  Towards safe injection practices for prevention of hepatitis C transmission in South Asia: Challenges and progress.

Authors:  Naveed Zafar Janjua; Zahid Ahmad Butt; Bushra Mahmood; Arshad Altaf
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

2.  Directly observed therapy of sofosbuvir/ribavirin +/- peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C-DOT).

Authors:  S S Solomon; M S Sulkowski; P Amrose; A K Srikrishnan; A M McFall; B Ramasamy; M S Kumar; S Anand; D L Thomas; S H Mehta
Journal:  J Viral Hepat       Date:  2017-08-14       Impact factor: 3.728

Review 3.  Improving Injectable Medicines Prescription in Outpatient Services: A Path Towards Rational Use of Medicines in Iran.

Authors:  Firoozeh Bairami; Fatemeh Soleymani; Arash Rashidian
Journal:  Int J Health Policy Manag       Date:  2016-03-05

4.  Prescription practices & use of essential medicines in the primary health care system, Shimoga district, Karnataka, India.

Authors:  Gudadappa S Kasabi; Thilakavathi Subramanian; Ramesh Reddy Allam; Chitra A Grace; Shivanna Reddy; Manoj V Murhekar
Journal:  Indian J Med Res       Date:  2015-08       Impact factor: 2.375

5.  Examining unsafe injection practices associated with auto-disable (AD) syringes: a systematic review.

Authors:  Anokhi Ali Khan; Mehr Munir; Fatima Miraj; Shayan Imran; Danya Arif Siddiqi; Arshad Altaf; Aamir Javed Khan; Subhash Chandir
Journal:  Hum Vaccin Immunother       Date:  2021-05-14       Impact factor: 3.452

6.  Assessment of knowledge, attitude, and practices toward prevention of hepatitis B infection among medical students in a high-risk setting of a newly established medical institution.

Authors:  Akanksha Rathi; Vikas Kumar; Jitendra Majhi; Shalini Jain; Panna Lal; Satyavir Singh
Journal:  J Lab Physicians       Date:  2018 Oct-Dec

7.  Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection.

Authors:  Antoine Chaillon; Sanjay R Mehta; Martin Hoenigl; Sunil S Solomon; Peter Vickerman; Matthew Hickman; Britt Skaathun; Natasha K Martin
Journal:  PLoS One       Date:  2019-06-06       Impact factor: 3.240

8.  Cost-Effectiveness of Therapeutic Use of Safety-Engineered Syringes in Healthcare Facilities in India.

Authors:  Pankaj Bahuguna; Shankar Prinja; Chandrakant Lahariya; Radha Krishan Dhiman; Madhumita Prem Kumar; Vineeta Sharma; Arun Kumar Aggarwal; Rajesh Bhaskar; Hilde De Graeve; Henk Bekedam
Journal:  Appl Health Econ Health Policy       Date:  2020-06       Impact factor: 2.561

9.  Patient safety in maternal healthcare at secondary and tertiary level facilities in Delhi, India.

Authors:  Chandrakant Lahariya; Ankita Choure; Baljit Singh
Journal:  J Family Med Prim Care       Date:  2015 Oct-Dec

10.  The Primary Care of Immigrant Workers and Their Associated Characteristics within A Taiwanese Fishing Community.

Authors:  Shih-Chao Kang; Chun-Chi Lin; Chia-Chen Tsai; Yin-Chieh Chang; Chi-Yi Wu; Ke-Chang Chang; Su-Shun Lo
Journal:  Int J Environ Res Public Health       Date:  2019-10-01       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.